Athersys Company Profile

04:48 EDT 31st August 2015 | BioPortfolio

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.

Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.

Location

3201 Carnegie Avenue
Cleveland
Ohio
44115-2634
United States of America

Contact

Phone: 216-431-9900
Fax: 216-361-9495
Email: jobs@athersys.com., ir@athersys.com


News Articles [45 Associated News Articles listed on BioPortfolio]

Athersys, Inc.: Athersys und Chugai schließen Lizenzvereinbarung und Zusammenarbeit zum Entwickeln der MultiStem(R)-Stammzellentherapie für ischämische Schlaganfälle in Japan ab

Partnerschaft im Bereich der regenerativen Medizin mit dem Schwerpunkt auf der Entwicklung einer neuen Stammzellentherapie CLEVELAND und TOKIO, 3. März 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nas...

Mark Your Calendar For Athersys

NEW YORK CITY (dpa-AFX) - Athersys Inc. (ATHX) is scheduled to present preliminary results from its phase 2 clinical trial of its investigational biologic product for the treatment of ischemic str...

Athersys (ATHX) - Chugai deal builds confidence

Edison Investment Research - Pharmaceutical & Healthcare - Athersys : The development of regenerative medicines in Japan presents a significant opportunity. Athersys has just taken a major step toward...

Athersys tanks on disappointing mid-stage stroke drug trial

US clinical-stage biotech firm Athersys has revealed that its stem-cell therapy, its only product to…

Athersys and Chugai announce pharma licensing deal for ischemic stroke

Athersys and Chugai Pharmaceutical have announced a partnership and pharma licensing agreement to exclusively develop and commercialize MultiStem cell therapy for ischemic stroke in Japan. Ischemic s...

Chugai-Athersys collaborate to develop MultiStem Cell Therapy

Biospectrum As part of the collaboration, Chugai will be responsible for the development and commercialization of Multi...

Athersys, Chugai partner on cell-therapy development, marketing

Athersys agreed to collaborate with Chugai Pharmaceutical to develop and market in Japan the former's MultiStem cell therapy, -More- 

Athersys stroke treatment fails mid-stage study

April 17 (Reuters) - Drug developer Athersys Inc said its experimental cell therapy did not meet the primary and secondary endpoints of a study testing it as a treatment for a type of stroke.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Athersys

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company ...

More Information about "Athersys" on BioPortfolio

We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Biopharmaceuticals
Latest News Clinical Trials Research Drugs Reports Corporate
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Mergers & Acquisitions
Latest News Clinical Trials Research Drugs Reports Corporate
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record